加速度计的体力活动与肝纤维化相反相关;纵向队列的横截面分析
Madeleine G Haff1, Joanne M Murabito2,3, Ramachandran S Vasan2,3,4
1Section of Gastroenterology, Department of Medicine, Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
概括
定期体育活动,特别是中度至强度体育活动 (MVPA),与成人肝纤维化几率降低有关. 每周达到150分钟的MVPA显示出与较低纤维化风险的最强相关性.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 代谢健康 代谢健康
- 运动生理学 运动生理学
背景情况:
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 可以进展到晚期肝纤维化,增加死亡风险.
- 身体活动在管理MASLD相关纤维化的作用需要进一步描述.
研究的目的:
- 调查加速仪测量体力活动 (PA) 与肝纤维化之间的横截面关联.
- 为了确定中度至强度的体力活动 (MVPA) 是否与肝纤维化减少有关,独立于BMI和肥胖症.
主要方法:
- 利用振动控制的短暂弹性图谱测量2201名成年人的肝硬和纤维化.
- 使用加速度计数据量化每日和每周的体力活动水平.
- 进行了多变量回归分析,对年龄,性别,BMI和酒精消耗等关键共变量进行调整.
主要成果:
- 观察到MVPA和肝纤维化之间存在显著的反向关联.
- 每增加每天30分钟的MVPA都会降低纤维化几率 (或0.57),即使在调整了BMI或脂肪酸.
- 每周接受150分钟MVPA的个体患肝纤维化的几率最低 (或0.51).
结论:
- 在以社区为基础的队列中,花费在中度至剧烈体力活动中的时间增加与肝纤维化相反相关.
- 身体活动可能在缓解MASLD肝纤维化进展方面发挥关键作用.
- 需要进一步的干预研究来探索MVPA在逆转肝纤维化的潜力.
相关概念视频
Ultrasound II: Endoscopic Ultrasound and FibroScan
544
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
544
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
180
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
180
Liver Physiology
3.5K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
3.5K


